Project Grant R43GM151920
Award Date
9/1/23
Completion Date
8/31/24
Dollars Obligated
$230K
Federal Agency
National Institute of General Medical Sciences
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Austin, TX 78744, USA
Similar Awards
The National Institute of General Medical Sciences (NIGMS) awarded a $305,892 project grant under the Biomedical Research and Research Training Program (CFDA 93.859) to Dotquant LLC, a biotechnology research and development company. The grant funding will support the development of a new in vitro transcription kit that combines the benefits of wild-type T7 RNA polymerase (high efficiency and low cost) with the ability to incorporate chemically modified nucleotides, like those used in RNA...
The National Institute of General Medical Sciences (NIGMS) awarded a $905,853 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to Molecular Instruments, Inc., a for-profit manufacturer of scientific instruments located in Los Angeles, California. The grant funding supports the company's research and development of novel signal amplification technologies to enable automated, ultrasensitive, and multiplex imaging of RNA and protein targets in biological samples. The proposed...
This $372,210 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research to develop fluorescent nucleoside analogues and apply them to advance RNA-centered therapeutics. The key products and services to be delivered include: Creating modified antisense oligonucleotides (ASOs) and short interfering RNAs (siRNAs) incorporating fluorescent ribonucleosides to enable live-cell imaging of RNA...
The National Institute of General Medical Sciences (NIGMS) awarded a $350,000 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Electronic Biosciences, Inc., a small biotechnology company in San Diego, California. The purpose of this grant is to develop and demonstrate a novel enzyme-based, single-molecule protein sequencing system. This innovative platform will leverage enzymatic processing and advanced bioinformatics to accurately sequence peptides with...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) is funding research to develop an enzyme-free, label-free quantitative microarray technology capable of detecting and quantifying small nucleic acid sequences, such as microRNA, at attomolar concentrations. The $432,834 award to the University of Nebraska aims to design a novel "binary probe" system and specialized opto-electrochemical...
The National Institute of General Medical Sciences (NIGMS) awarded a $307,257 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to Sxrna Technologies, Inc. The grant, titled "SXRNA-SELECT: USING RNAS FOR POSITIVE SELECTION OF CELL LINES, ENABLING HIGH-YIELD BIOTHERAPEUTIC PRODUCTION", aims to develop a rapid cell cloning technology called SXRNA-SELECT that will decrease the time and cost of producing biotherapeutic proteins. The project will optimize the...
The National Institute of General Medical Sciences (NIGMS) awarded a $300,518 Project Grant under CFDA 93.859 (Biomedical Research and Research Training) to E&E Bioclub LLC in Indianapolis, IN. The grant aims to develop an all-in-one platform for intracellular overproduction of long, single-strand mRNA. This addresses the challenges of cost, scalability, and heterogeneity faced by current mRNA manufacturing methods, which are dominated by enzymatic in vitro transcription processes. The...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $2,378,837 in funding to the University of Massachusetts to develop novel nanopore- and click-chemistry-based approaches for accurate detection of sepsis-causing pathogens directly from blood samples. The goal is to create a rapid, user-friendly diagnostic device prototype that can identify sepsis-causing microorganisms within 2...
This $1,539,200 federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) supports the development of an integrated technology platform to characterize the conformational flexibility, heterogeneity, and dynamics of functional oligonucleotides. The key products to be delivered include: A novel ionization technique called Capillary Vibrating Sharp-Edge Spray Ionization (CVSSI) that...
The National Institute of General Medical Sciences (NIGMS) awarded a $350,000 SBIR Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to Quantitative Biosciences, Inc. (QBiSci.com), a for-profit company in San Diego, CA. The grant aims to develop a neural network-accelerated DNA and RNA sequence processing node, called CLEDGESEQ, for distributed next-generation sequencing (NGS) data processing at the point of sequencing. The key objectives are to: 1) Develop neural...